Roger F Sewell (Roger Sewell)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Chronic Kidney Disease

Anti Inflammatory

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, Prema Shanmugasundaram, Anilkumar Jain, Marasamy Bathragiri, Manoranjan Pattnaik, Jyotirmayee Turuk, Ramesh Karunaianantham, Senthilkumar Balakrishnan, Sangamitra Pati, A K Hemanth Kumar, Manoj Kumar Rathore, Jegadeesh Raja, K Raghu Naidu, John Horn, Laura J Whitworth, Roger F Sewell, Lalita Ramakrishnan, Soumya Swaminathan, Paul H Edelstein
A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis. Clinical pharmacology and therapeutics (2023)
Laura J Whitworth, Jacob Coxon, Arjan van Laarhoven, Nguyen Thuy Thuong Thuong, Sofiati Dian, Bachti Alisjahbana, Ahmad Rizal Ganiem, Reinout van Crevel, Guy E Thwaites, Mark Troll, Paul H Edelstein, Roger F Sewell, Lalita Ramakrishnan
A Bayesian analysis of the association between Leukotriene A4 Hydrolase genotype and survival in tuberculous meningitis. eLife 10 (2021)
Laura J Whitworth, Rajan Troll, Antonio J Pagán, Francisco J Roca, Paul H Edelstein, Mark Troll, David M Tobin, Nguyen Hoan Phu, Nguyen Duc Bang, Guy E Thwaites, Nguyen Thuy Thuong Thuong, Roger F Sewell, Lalita Ramakrishnan
Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone. Proceedings of the National Academy of Sciences of the United States of America 118 (10) (2021)